Background: NMDAR subunit plasticity governs its function in health and disease. Results: Substitutions of key amino acids in conantokins change their selectivity for NMDAR subunits. Conclusion: Incorporation of hydroxyproline into conantokins substantially alters their structures and functions as NMDAR subunit-selective ion channel antagonists. Significance: Conantokins can be designed to display selective NMDAR antagonist properties.
The conantokins are a class of neuroactive peptides that are naturally produced in venoms of the Conus genus of predatory marine snails. A characteristic distribution of post-translationally generated ␥-carboxyglutamate (Gla; ␥) residues provides these peptides with distinct structural and functional properties. In the presence of divalent ions, many conantokins from different species of Conus-derived venoms adopt an ␣-helical structure, whereas conT and conR, from Conus tulipa (1) and Conus radiates (2) , respectively, are inherently ␣-helical, even in the absence of divalent metal cations. Functionally, the conantokin peptides are subunit-selective antagonists of the N-methyl-D-aspartate receptor (NMDAR). 2 These receptors, located in the brain and spinal cord regions, are voltage-and ligand-gated ion channels that have considerable functional plasticity depending on their exact subunit combinations, which are regionally and developmentally controlled in the brain in health and disease.
The activation of the ion channels of the NMDAR is achieved by the release of a voltage-dependent ion channel Mg 2ϩ block through co-activation by NMDA or Glu, along with Gly. The functional NMDAR heterotetramer is composed of two Glybinding GluN1 subunits and two NMDA-binding GluN2 subunits (3) . Ubiquitously expressed GluN1 contains two of any of eight alternatively spliced isoforms (GluN1a-h) (4) , which coassemble with two GluN2 subunits (5) that are expressed by any of four separate genes (Grin2ad) (6) . The exact NMDAR subunit composition is variable and depends upon the stage of development and location of the heterotetramer in neuronal populations (7) . Additionally, the variable compositions of functional NMDARs also determine the nature of their interactions with agonists/antagonists (8) . Activated NMDARs allow influx of Na ϩ and Ca 2ϩ and efflux of K ϩ . Ca 2ϩ then functions as a secondary messenger, which further activates, by phosphorylation, the cAMP-response binding element, via a Ca 2ϩ /calmodulin-dependent pathway (9, 10) . Additionally, NMDARs also bi-directionally regulate activation of PI3K-Akt (11) (12) (13) and ERK1/2 (14, 15) .
Although such downstream signaling activities are at the physiological basis of learning and memory, hyperactivation of NMDARs, due to sustained pathological glutamate exposure, has a causal relationship with several neuropathologies. For example, NMDARs primarily dominated by the GluN2B subunit were found to be overexpressed in Huntington and Parkinson diseases, pain, opiate addiction, stroke, and epileptogenesis (16 -20) . ConG, from Conus geographus, the first conantokin discovered, was established as a GluN2B-selective antagonist (21) . Further interest in conantokins was pursued due to their potential as NMDAR subunit-selective neuroprotective agents in disease states.
In an attempt to unravel the relationships between primary sequences, three-dimensional structures, and neuronal functions of diverse conantokins, various studies were initially performed with conG, conT, and conR. On comparing their primary sequences, these peptides were shown to share a high sequence homology, including a largely invariant N terminus of 1 GE␥␥ 4 . ConG differs from many other conantokins in possessing an additional Gla at sequence position 7. Gla 7 destabilizes helix formation due to charge repulsions that would occur in Gla residues in an ␣-helix at i,i ϩ 4, i ϩ 7, and i ϩ 11 in the absence of metal cations (22) . As a result of this inclusion of Gla 7 , conG is unstructured in the absence of divalent ions, whereas conT, containing Lys at position 7, exists as an ␣-helix in the absence of divalent cations. This is likely due to favorable side chain charge-charge interactions with Lys 7 and Gla residues 4 and 11 in helical turns (22, 23) . Conantokins bearing systematic Ala substitutions at individual residues revealed the interdependence between the 5 and 6 N-terminal residues and NMDAR ion channel inhibitory properties (24) . However, the relationships between the overall secondary structural characteristics of conantokins and primary sequence-derived functional properties still remain unclear.
Apart from the existence of Gla residues, some conotoxins contain 4-hydroxyproline (Hyp) (25) , formed post-translationally via prolyl-4-hydroxylase catalysis. In animals, this amino acid is found mainly in collagen/gelatin/elastin and stabilizes the collagen triple helix. Hyp also occurs in very small amounts in other proteins, e.g. cellular prion protein (26) , argonaute 2 (27) , hypoxia-inducible factor (28) , and complement C1q (29) , with functional consequences in secretion, protein folding, and stability, activity, receptor recognition, and/or glycosylation. Additionally, conantokins from Asprella clade, a genus within the Conidae family that is closely related to the genus Conus, were discovered that contain 1 residue of Hyp centrally located in the peptide (30, 31) . The presence of Hyp at sequence position 10 of conRl-B from A. clade is of particular interest, because intuitively it would, at a minimum, negatively influence the ability of conantokins to form divalent cation-induced endto-end helices. To determine the role of Hyp in the structurefunction relationships of conantokins, we combined a high resolution structural study of conRl-B, obtained by NMR spectroscopy, with evaluations of its ion channel antagonism of NMDARs in intact neurons containing specific subunit gene inactivations. The results of these studies are summarized herein.
Experimental Procedures
Peptide Synthesis-The following conantokins were chemically synthesized on a 0.1 mmol scale using standard N-(9-fluorenyl)methoxycarbonyl (Fmoc)-protected amino acids (Novabiochem) by solid phase peptide synthesis employing a model 433A (Applied Biosystems, Foster City, CA) peptide synthesizer (32) , where ␥ refers to ␥-carboxyglutamate and O to 4-Hyp. N ␣ -Fmoc-(␥,␥Ј-di-OtBu)-L-Gla was synthesized as described previously (33) . The following were used: conRl-B, GE␥␥LA␥KAO 10 ␥FAR␥LAN-CONH 2 ; conRl-B[⌬K 8 Circular Dichroism (CD)-The CD spectra of the peptides without Mg 2ϩ , and with a saturating level of Mg 2ϩ , were measured using an AVIV model 62DS spectrometer with a 1-cm path length cell. The relevant peptides were dissolved in a solution of 10 mM HEPES, 10 mM NaCl, pH 7, to a final concentration of 100 M. The ␣-helical contents of these peptides were calculated as a percentage of the molar ellipticity values at 222 nm for Mg 2ϩ /conG, which is known to exist as an end-to-end ␣-helix.
NMR Spectroscopy-The samples for NMR measurements were prepared by dissolving the purified peptide to a final concentration of 2 mM in a solution containing 10 mM [ 2 H]HEPES, 40 mM MgCl 2 , pH 7.0. 2 H 2 O (10%) was added to the peptide solutions to provide the 2 H lock signal. 4,4-Dimethyl-4-silapentane-1-sulfonate was added as an internal reference.
All NMR spectra were recorded at a temperature of 298.1 K on a four-channel Bruker AVANCE II spectrometer at a field strength of 18.79 T using a 5-mm inverse triple-resonance ( 1 H/ 13 C/ 15 N) z axis pulsed field gradient cryoprobe, and running the TopSpin 3.2 pl6 software. The 1 H, 13 C, and 15 N chemical shifts for each residue were determined by analyzing two-dimensional homonuclear DQF-COSY, TOCSY (60 ms), and NOESY (120 and 200 ms) spectra, as well as heteronuclear 1 H-13 C HSQC, HSQC-TOCSY, HMBC, and 1 H-15 N HSQC spectra. The spectra were measured using standard pulse sequences in the Bruker TopSpin 3.2, pl6 pulse sequence library. Suppression of the water signal was accomplished by Watergate or Echo-Antiecho techniques. Proton chemical shifts were referenced to internal 4,4-dimethyl-4-silapentane-1-sulfonate. The 13 C and 15 N dimensions in two-dimensional heteronuclear spectra were referenced indirectly (34) . The NMR data were processed and analyzed with the programs TopSpin (Bruker Instruments) and Sparky.
Free induction decays were acquired with 2K complex data points for the TOCSY and NOESY data sets and with 4K complex data points for DQF-COSY experiments. A total of 400 t1 increments were collected for NOESY, 300 -350 for TOCSY, and 512 for DQF-COSY data sets. Experimental data were zerofilled to double the original data points and apodized with a 90°t o 60°shift square sine bell window function.
Residue-specific assignments of the 1 H resonances were performed by standard methods using DQF-COSY, TOCSY, and 15 N-HSQC, followed by sequential assignments through NOE connectivities (35, 36) . Dihedral angle ( and ) restraints were obtained from chemical shift data using the program TALOSϩ (37, 38) .
The samples for solvent exchange experiments were prepared by first lyophilizing the conantokin samples in 10 mM HEPES, 40 mM MgCl 2 , pH 7.0. The peptide was next redissolved in the same volume of 100% 2 H 2 O to initiate exchange. Multiple one-dimensional 1 H spectra were acquired at 278 K during the exchange. Spectra were processed using 1 Hz exponential line broadening with zero filling to 16 K. Rates of exchange of individual backbone amide protons with solvent 2 H atoms were estimated by fitting a single exponential decay function to the peak height of the resonances. Additionally, two-dimensional TOCSY experiments were performed to assign resonances of the backbone amide protons participating in a slow chemical exchange with solvent.
Structure Calculations-The intensities of the cross-peaks in the NOESY spectra of the conantokins were classified from the number of contours as strong, medium, or weak and converted to distance upper bounds of 3.0, 4.0, and 5.7 Å, respectively. All side-chain/side-chain or side-chain/main-chain medium range (i,i ϩ 2, and i,i ϩ 4) constraints were set to an upper bound of 6 Å and a lower bound of 1.8 Å. Dihedral angle restraints ( and ) were derived from chemical shift values of H N , N, CO, C ␣ , and C ␤ using TALOSϩ (37, 38) . The solution structures of conantokins were solved using standard simulated annealing protocols as implemented in Xplor-NIH 2.37 (39, 40) . NOEderived interproton distance restraints and dihedral angle restraints, predicted from NMR chemical shifts using TALOSϩ, were incorporated into restrained molecular dynamics followed by energy minimization with an all-atom force field. After global folding and refinement, the converged structures were accepted on the basis of low total energy, the avoidance of bond violations of Ͼ0.10 Å, torsion angle violations of Ͼ5.0°, improper violations of Ͼ5.0°, dihedral violations of Ͼ20°, van der Waals violations of Ͼ1.7, and NOE distance violations of Ͼ0.3 Å. The 20 lowest energy conformers most consistent with the experimental NMR data were chosen as representative conformers of the ensemble of conantokin protein structures. The stereochemistry and quality of these structures were analyzed using PROCHECK-NMR (41) and the protein structure validation suite. Statistics resulting from the structural calculations and assessment of the structural quality of the calculated protein models are presented in Table 1 . Visualization of the structures was performed using PyMOL.
Docking of Metal Ions into Conantokins-The positions of Mg 2ϩ in conRl-B were first predicted by combining results from previous isothermal calorimetry titrations, showing ϳ2 g atoms of Mg 2ϩ /mol peptide (42) , and the electrostatic map determined by AutoDock Tools. The grid size was set to a box containing the whole conantokin structure with a spacing of 0.375 Å between grid points. The polar hydrogen and Gasteiger charges were added by AutoDock Tools. The Lamarckian Genetic Algorithm was chosen as the docking search parameter. Further energy minimization-based refinement was carried out using the same protocol for the structural determination of Mg 2ϩ -loaded conantokins (43) . Here, the 200 lowest energy structures calculated by NMR in the previous step were used as the new starting model. The Mg 2ϩ coordinate restraints taken from the crystal structure (Protein Data Bank code 1ONT) were added as metal ion-binding coordinates.
Molecular Dynamics Simulations-The simulations were performed using the Amber14 program (44) . The ff13 all-atom force field (45) was used for standard amino acid residues, whereas the GAFF force field was used for the nonstandard amino acid residues, Gla and Hyp. Their partial charges were obtained by the restrained electrostatic potential method (46) , based on geometric optimizations at the B3LYP/6 -31G(d) level. We also tested the ff10 and ff12SB force fields, which were found to give very similar results as ff13. Hence, only the results from the ff13 force field are presented. The average energyminimized NMR solution structures for conG, conRl-B, conRl-B[⌬K 8 AON 8 Q], and con-G[O 10 ] were used as the initial structure for MD simulations, which were neutralized by adding Cl Ϫ , and explicitly solvated by TIP3P water molecules in a periodic box. The distance between the box walls and the protein surface was set at 10 Å. An additional Mg 2ϩ and two Cl Ϫ were added to the system to adjust the concentration of MgCl 2 to 0.01 M. The system was then minimized, gradually heated to 300 K, and equilibrated at 1.0 atm and 300 K for 400 ps. A 200-ns production run was performed with a time step of 2 fs at 1.0 atm and 300 K under NPT conditions. The temperature was controlled by Langevin dynamics with a collision frequency of 1.0 ps Ϫ1 , and the pressure was maintained by isotropic position scaling (47) . The nonbonded cutoff distance was set at 10 Å. The SHAKE algorithm (48) was used to constrain all bonds that contain hydrogen. The particle mesh Ewald (PME) method (49) was used to treat long range electrostatic interactions.
Cell Cultures of Dissociated Primary Neurons-Primary mouse cortical cell cultures were prepared from embryonic day 18 for WT, GluN2A Ϫ/Ϫ , and GluN2B Ϫ/Ϫ mice as described (50) . Mice heterozygous for the GluN2A (GluN2A ϩ/Ϫ ) or the GluN2B (GluN2B ϩ/Ϫ ) allele were bred separately, and the embryos were harvested and genotyped for the GluN2A Ϫ/Ϫ or GluN2B Ϫ/Ϫ alleles, which were used for neuron culture.
Dissociation of brain tissue was carried out using 1 mg/ml papain. Neurons were plated on 35-mm tissue culture-treated dishes (Corning Life Sciences, Lowell, MA) coated with poly-Llysine. Neurobasal medium (Invitrogen), supplemented with 2% B27 (Invitrogen), 1% L-Glu, was used to maintain the cell cultures at 37°C in a humidified atmosphere with 5% CO 2 .
Whole Cell Patch Clamp Electrophysiology-Neurons from days in vitro 12-15 for WT, GluN2A Ϫ/Ϫ , and GluN2B Ϫ/Ϫ mouse brains were plated at cell densities of ϳ2.5 ϫ 10 5 on 35-mm tissue culture-treated dishes (Corning Life Sciences). The cells were then placed in an extracellular solution composed of 10 mM HEPES, 140 mM NaCl, 3 mM KCl, 2 mM CaCl 2 , pH 7.35. Borosilicate glass recording pipettes (Drummond Scientific, Broomall, PA), with a resistance of 2-4 megohms, pulled using a Flaming/Brown Micropipette Puller model P-97 (Sutter Instruments), were back-filled with an intracellular solution of 10 mM HEPES, 140 mM CsF, 2 mM CaCl 2 , 10 mM EGTA, 2 mM tetraethylammonium chloride, 4 mM Na 2 ATP, pH 7.35.
The cells were visualized using a Nikon Eclipse TE200 microscope. Initially, dose-response curves were established utilizing 5, 10, and 20 M conantokins. From these experiments, we found that conantokin concentrations of 10 M provided nearmaximal (90 -95%) inhibitions in all cases. Prior to patching, the cells were washed with artificial cerebral spinal fluid (1 M tetrodotoxin (TTX), 0.5 M strychnine), and the neurons were patched and voltage-clamped at Ϫ70 mV in the same solution. A solution of 50 M NMDA, 10 M Gly, 1 M TTX, 0.5 M strychnine was applied to the neurons for 3 s. After the neurons were washed free of agonists with artificial cerebral spinal fluid, conantokins (10 M) were preincubated with the neurons for 1 min. Next, the neurons were restimulated with the agonist solution (10 M conantokins, 50 M NMDA, 10 M Gly, 1 M TTX, 0.5 M strychnine). An Axopatch-200B amplifier (Axon Instruments, Foster City, CA) was used to record the whole cell current, low pass filtered at 5 kHz by a built-in eight-pole Bessel filter, and digitized at a 1-kHz sampling frequency using a Digidata 1322A signal conditioning amplifier (Axon Instruments). pCLAMP-8 software (Axon Instruments) was used to acquire the data. The patch clamp technique for whole cell recordings was performed to specifically assess inhibitory functions of the different conantokins. Responses generated in the presence of antagonists were reported as % inhibition, normalized to the maximum current in the absence of conantokins. The data obtained were analyzed utilizing Clampfit and Prism GraphPad and reported as Ϯ S.E. from at least three batches of different neuron populations.
A comparison of the decay times between WT and GluN2A Ϫ/Ϫ neurons was calculated using a weighted mean decay time constant
where I f and I s are the amplitudes of the fast and slow decay components, and t f and t s are times in milliseconds corresponding to the I f and I s , respectively. Data values are expressed as mean Ϯ S.E.
Results
Cation-induced ␣-Helicity Observed by CD-CD experiments were designed to reveal the maximal helicity adopted by various conantokins in the presence of saturating Mg 2ϩ . The structure of conG is a well accepted end-to-end ␣-helix in the presence of physiologically important cations, such as Ca 2ϩ , Mg 2ϩ , and other relevant divalent cations, e.g. Zn 2ϩ and Cd 2ϩ (42, 43, 51, 52) . To overcome the unreliability of CD-based analytical algorithms to predict the helical content of very small peptides, especially with modified amino acids present, the molar ellipticity at 222 nm ( 222 ) was designated a value of 100% for the Mg 2ϩ ⅐conG complex and 0 for apo-conG, values consistent with high resolution structural determinations of conG (23, 43) . Thus, the ␣-helical contents of the conantokin peptides were estimated based empirically on the following relationship: % conantokin helicity ϭ ( 222 peptide)/(( 222 Mg 2ϩ / conG) Ϫ ( 222 apo-conG)) ϫ 100. The data obtained showed that apo-conRl-B, in which 4-Hyp is present at sequence position 10 (Hyp 10 or O 10 ), contains Ͻ5% helical content ( Fig. 1A) , similar to other published data (54) . The synthetic variants, apo-conG[O 10 ] (Fig. 1B) , with an insertion of Hyp 10 , and apo-conRl-B[⌬K 8 AON 8 Q], with a deletion of Hyp 10 (Fig. 1C ) and exchange of the immediate upstream two amino acids to those that more closely resemble conG, also show similarly low ␣-helical values. In contrast, each of these peptides demonstrate Ͼ60% ␣-helicity when saturated with Mg 2ϩ (Fig. 1 , A-C). These data suggest that the Hyp 10 allows a large conformational rearrangement to a more helical structure in the presence of Mg 2ϩ . That Mg 2ϩ /conG[O 10 ] shows a full helical structure, at least as estimated by CD, suggests that Hyp 10 , in the context of the conG backbone, permits global folding of the peptide that resembles a full ␣-helix. In an overall sense, these data show that Mg 2ϩ binds to the Hyp 10 -containing peptides, thus allowing adoption of helix-like structures that are most likely composed of short local segments within the peptides. These low resolution conformational studies provide an impetus for obtaining the high resolution Mg 2ϩ -dependent structures of these 4-Hyp-containing peptides to determine the manner in which 4-Hyp allows the organization of a helical folding state dependent on Mg 2ϩ binding.
High Resolution Structures Identified by NMR-High field NMR spectra were recorded from a solution containing conRl-B ( Fig. 2A The peptide concentrations were 100 M, and the MgCl 2 concentrations were 2 mM, when present. The buffer was 10 mM HEPES, pH 7, at 25°C. Each curve represents an average of three scans, and the percent helicity is determined as a percent of molar ellipticity of Ϫ22,081 degrees cm 2 dmol Ϫ1 , which is observed for conG ϩ 2 mM MgCl 2 and represents 100% ␣-helicity of these classes of peptides.
noise ratios, and the resolutions were consistent with 1 H NMR studies previously carried out for Mg 2ϩ /conG (43, 55) . Additionally, the dispersions of the amide proton resonances were sufficiently large to allow complete assignments of the proton resonances of the peptides in the presence of Mg 2ϩ . In particular, the Gla residues were easily identifiable because of the characteristic downfield shift of the C␥ protons (3.5-3.7 ppm) when compared with the C␥ of Glu (2.3-2.4 ppm). The crosspeaks in NOESY spectra included short range and medium range distance constraints from backbone and medium range NOEs between residue side chains, which all suggest the existence of ␣-helices ( Fig. 3, A-C) .
The spectra obtained provided a full set of 1 H, 13 C, and 15 N chemical shifts for each Mg 2ϩ ⅐peptide complex, which, in addi- tion to the primary sequence information, were used by TALOSϩ (38) to predict backbone torsion angles ( and ) for individual amino acids of the peptides. Graphical representations of the TALOSϩ-derived secondary structure predictions for each Mg 2ϩ ⅐peptide complex are shown ( Fig. 4, A-D) . Here, it is seen that, for Mg 2ϩ ⅐conRl-B (Fig. 4A ), all residues except Ala 9 were classified as unambiguous secondary structure pre-dictions with appropriate dihedral angles. The resultant secondary structure prediction by TALOSϩ was found to be indicative of an ␣-helix, with a more flexible conformation for residues Lys 8 -Ala 9 -Hyp 10 -Gla 11 (Fig. 4A) . Similarly, the dihedral angle prediction of Mg 2ϩ /conG[O 10 ] displayed an ␣-helix that was locally disrupted by a more obvious flexible region for Asn 8 -Gln 9 -Hyp 10 (Fig. 4B ). This disruption resulted in higher flexibility of that same region of conRl-B (Fig. 4B) , as evidenced by the lower random coil index model free order parameter (RCI-S2; Fig. 4B ), in this region of the peptide. For both of these peptides, the chemical shift values from TOCSY, independent of NOE-based assignments, confirm a break in the ␣-helix backbone caused by the presence of Hyp 10 with Ͻ2.5% error. In contrast, the same data predicted that Mg 2ϩ /conG ( The Mg 2ϩ ⅐conRl-B structure was calculated from 246 distance restraints that included 128 intraresidue, 69 sequential, 44 medium range, and 30 dihedral angle restraints (Table 1) Table 1 ). The structures were then confirmed for the absence of violations and the percentage of those present in a favorable region on a Ramachandran plot, using PROCHECK (41) . A cluster of 20 energy-minimized backbone and backbone ϩ side chain structures were obtained for the Mg 2ϩ ⅐peptide complexes ( At a lower temperature of 5°C, the Mg 2ϩ ⅐conRl-B complex exists as a less dynamic structure that resulted in an increased number (252) of NOE distance constraints. Temperature-dependent NH and ␣H chemical shifts resulted in ambiguous prediction of dihedral angles by TALOSϩ. Thus, these restraints were not included in the structural calculations for conRl-B (Table 1) . Twenty structures were generated by Xplor-NIH, based on NOE restraints. This structure differs from that at 25°C, in that a tighter C-terminal helix was observed after the disruption caused by Hyp 10 (Fig. 7A) . Comparatively, the chemical shifts at 5°C for conG[O 10 ] offered a better prediction of dihedral angles by TALOSϩ that complemented the NOE data to deduce a solution structure. The Mg 2ϩ ⅐conG[O 10 ] complex at 5°C is similar to the structure generated at 25°C (Fig.  7B ). The break in the ␣-helix created by introduction of Hyp 10 occurs in residues 8 -10.
Finally, the chemical shift data were employed in the Promega program (56) to predict whether the Hyp 10 peptide bonds of conRl-B and conG[O 10 ] were in the cis-or trans-conformations. For Mg 2ϩ ⅐conRl-B, the trans/cis probability score was calculated to be Ͼ99% for Hyp 10 in the trans-conformation, and for conG[O 10 ], the probability of Hyp 10 residing in the trans-conformation approached 90%.
Hyp-induced Disruption in the Mg 2ϩ /ConRl-B ␣-Helix-As shown in Fig. 3 , the presence of Hyp 10 in conRl-B and conG[O 10 ] caused loss of sequential H ␣ -H N (i,i ϩ 1), and medium range H ␣ -H N (i,i ϩ 3) NOE connectivities for residues 8 -10 in the fingerprint regions of the NOESY spectra, suggesting that Hyp induced a kink in the ␣-helical structure of these two peptides. However, the presence of long range backbone/ side-chain NOE contacts, such as H ␣ -H ␤ (i,i ϩ 3) between Ala 9 and Phe 12 , was found in conRl-B (Fig. 3A) . Such interactions were very weak between Asn 8 and Gla 11 in the NOESY spectra of conG[O 10 ] (Fig. 3B) . This confirmed the predictive data that this region of conRl-B is somewhat more structured and less flexible than that of conG[O 10 ], and it may be better coordinated with functional properties in the natural backbone. The cross-peaks, NH-␣H, of Glu 2 and Glu 3 , Gla 4 and Leu 5 , Gla 7 and Lys 8 , and Gla 15 and Leu 16 ( Fig. 2A) , resulted in readily detectable sequential H ␣ -H N NOE peaks for conRl-B (Fig. 3A) . In com-parison, similar H ␣ -H N (i,i ϩ 1) NOE interactions identified for conG[O 10 ] were of lower intensity (Fig. 3B ). This further indicated a break in the ␣-helix three-dimensional structure due to Hyp 10 that was more pronounced than for conRl-B. Thus, the presence of Hyp 10 in both cases did not result in the same extent of disruption of the helix in conRl-B and conG [O 10 ]. Proton resonances from conRl-B[⌬K 8 AON 8 Q], a peptide similar to conG, show the presence of an ␣-helical backbone, as well as defined side chains that are indicated by many backbone/side chain and side chain/side chain NOE connectivities, especially for residues 4 -14 (Fig. 3C ). In the absence of a Hyp residue, sequential NOE connectivities were observed in the fingerprint region of H ␣ -H N for residues 9 -12 of conRl-B[⌬K 8 AON 8 Q] (Fig. 2C) .
Binding Sites of Mg 2ϩ in the Conantokins-To incorporate Mg 2ϩ in the structure of the peptides, an electrostatic grid map was generated for the average solution structure to explore the most negatively charged areas in the structure, which would be the most likely binding sites for Mg 2ϩ . The Mg 2ϩ was positioned in these structures with Autodock. ConRl-B ( JULY 17, 2015 • VOLUME 290 • NUMBER 29
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were less reliable because each site had a K d Ͼ300 M), it appears that Mg 2ϩ is coordinated with Gla 3 /Gla 7 and Gla 10/11 / Gla 14/15 in each case.
Mg 2ϩ binding to the Gla residues offers protection to the peptidic backbone amide protons. The extent of this protection, and the lifetime of local ␣-helicity, can be revealed by peptide-solvent 1 H-2 H exchange experiments using NMR. ConRl-B exhibited a very fast exchange rate of backbone amide 1 H signals within the first 30 min after the sample was dissolved in 2 H 2 O at 5°C (Fig. 10A ). The only visible peaks after the 4-min dead time of the experiment belong to Gla 15 , with an amide proton chemical shift of 8.53 ppm, and a group of amide proton peaks that are assigned to Gla 11 , Ala 13 , Arg 14 , and/or Leu 16 . Although a t1 ⁄ 2 of Ͻ4 min clearly ensued due to weak binding to Mg 2ϩ for conRl-B, the evident stability of the C terminus is qualitatively similar to that observed for proton exchange carried out for conG ( Fig. 10B ). Here, Gla 10 and Gla 14 , along with Leu 11 and Ile 12 , are completely shielded to solvent. For N-terminal residues, including Gla 7 , the backbone amide protons are more readily available for solvent exchange, resulting in t1 ⁄ 2 of Ͻ4 min. It is interesting to note that the backbone amide protons of conG[O 10 ], with a similar placement of Hyp as in conRl-B, is better protected from solvent exchange (Fig. 10C ). Discernible backbone amide proton signals assigned to Gla 15 , Lys 16 In the case of conRl-B (Fig. 11A ), one Mg 2ϩ binds with two oxygens from ␥-carboxylates of Gla 3 and two similar oxygens from ␥-carboxylates of Gla 7 in addition to oxygens from two H 2 O molecules, thus providing the hexacoordination arrangement typical for Mg 2ϩ . A second Mg 2ϩ binds to two oxygens from ␥-carboxylates of Gla 11 , one oxygen from Gla 15 ␥-carboxylates, and three H 2 O molecules. Only slightly different coordination of Mg 2ϩ is found for conRl-B[⌬K 8 AON 8 Q] (Fig.  11B) , which shows that one Mg 2ϩ binds with one ␥-carboxylate oxygen from Gla 3 and two oxygens from ␥-carboxylates of Gla 7 . Binding to oxygens from three H 2 O molecules completes Mg 2ϩ coordination at site 1. At the second C-terminal Mg 2ϩ -binding site, Mg 2ϩ binds with two ␥-carboxylates oxygens from Gla 10 , one ␥-carboxylate oxygen from Gla 14 , and oxygens from three H 2 O molecules.
For conG (Fig. 11C) , one Mg 2ϩ binds with one oxygen from the ␥-carboxylates of Gla 3 , two oxygens of Gla 7 , and oxygens from three H 2 O molecules, a coordination scheme for this site that is identical to that of conRl-B[⌬K 8 (Fig. 11D) , provides a structure consistent with the binding of one Mg 2ϩ to two oxygens from ␥-carboxylates of Gla 3 , two from Gla 7 , and oxygens from two molecules of H 2 O. At the second site, Mg 2ϩ is coordinated with two oxygens from ␥-carboxylates of Gla 11 , two from Gla 15 , and oxygens from two molecules of H 2 O. The MD simulations of Fig. 11, A-D, were performed without backbone restraints, thus causing partial loss of the helical peptide backbones that are not in the vicinity of the Mg 2ϩ sites. However, this did not affect the nature of the Mg 2ϩ ligands described above. As an example, when Mg 2ϩ /conG was simulated under the same conditions with a backbone restraint of 1 kcal/mol/Å 2 (Fig. 11E) , the ␣-helical backbone was preserved, and the Mg 2ϩ /peptide ligands were identical to those in MD simulations without backbone restraints (compare Figs. 11, C and E).
Thus, Mg 2ϩ coordination is very similar for each of the conantokins, involving only Gla carboxylate side chains and H 2 O molecules. There are possible slight orientation differences of Gla residues in the helices, perhaps due to their interactions with other side chains, e.g. Arg 14 -Gla 15 in the peptides, and/or due to reorientations due to the presence of Hyp, that lead to a small K d difference for Mg 2ϩ .
Effect of conRl-B and Mutant Peptides on Current Flow via NMDARs in Mouse Cortical Neurons-The release of the Mg 2ϩ
channel block in the NMDAR by application of the co-agonists NMDA (or Glu) ϩ Gly leads to the activation of NMDAR ion channels and consequent influx of Ca 2ϩ . Thus, the efficacies of conantokins as NMDAR antagonists were examined by measuring the decreases of NMDA/Gly-mediated current flow into mature (days in vitro 13-15) WT neurons, which contain NMDARs of many different subunit subclasses, the compositions of which change temporally and regiospecifically in health and disease. Here, we employed whole cell electrophysiological measurements on a variety of neuron types after stimulation by NMDA/Gly in the absence and presence of the conantokins, to calculate their effectiveness as inhibitors of current flow. From initial dose-response curves, it was determined that 10 M peptide yielded near maximal (ϳ90%) inhibition for NMDA/Glyevoked current, as well as for inhibition for NMDA/Gly-stimulated intracellular Ca 2ϩ influx (data not shown).
Examples of the types of measurements of NMDA/Gly-stimulated inward current, using conRl-B as the inhibitor, in WT neurons and in neurons that genetically lack GluN2A and GluN2B, are shown in Fig. 12 , A-C. It was observed that the deactivation kinetics, calculated as weighted mean decay time, t w for GluN2A Ϫ/Ϫ neurons, were longer due to the predominant presence of GluN2B, and possibly the presence of GluN2C or GluN2D subunits (t w ϭ 1053 Ϯ 50 ms for WT cells and t w ϭ 1621 Ϯ 1 ms for GluN2A Ϫ/Ϫ neurons, p ϭ 0.007). However, in this communication, our objective was only to assess the antagonistic potency of conRl-B on NMDARs. It is seen that conRl-B is a strong inhibitor (80%) of NMDARs in WT mouse cortical neurons ( Fig. 12A ) and in GluN2A Ϫ/Ϫ neurons (88%; Fig. 12B ), but it is ineffective in GluN2B Ϫ/Ϫ neurons (6%; Fig. 12C ). This suggests that NMDARs containing the GluN2B subunit is a preferred subtype for conRl-B inhibition of flow-through NMDAR ion channels. It is important to note that the absence of Hyp 10 in conRl-B[⌬K 8 AON 8 Q] and insertion of Hyp 10 in conG[O 10 ] have disruptive effects on the inhibitory function of the conantokins. In the case of conRl-B, removal of the natural Hyp causes loss of activity, and for conG, insertion of Hyp 10 into conG also causes a loss in activity. Thus, the naturally occurring peptides were well designed to be functional with Hyp present (conRl-B) or absent (conG) within the natural backbones of the conantokins.
Quantitations of the inhibitory activity of conantokins in WT neurons, GluN2A Ϫ/Ϫ neurons, and Glu2B Ϫ/Ϫ neurons are shown in Fig. 12 , D-F, respectively. Both conRl-B and conG inhibit ϳ80% of NMDA/Gly-mediated current influx in WT adult neurons (Fig. 12D) . Both of the mutants, one in which the natural Hyp 10 In GluN2A Ϫ/Ϫ adult mouse cortical neurons, both conRl-B and conG greatly inhibit NMDA/Gly-stimulated current flow ( Fig.  12E ), suggesting that the other dominant NMDAR, subtype GluN1/GluN2B, is a major target for conRl-B and conG. This conclusion is supported by data from similar studies on GluN2B Ϫ/Ϫ adult neurons (Fig. 12F) , where greatly attenuated inhibition of current flow is observed for both conRl-B and conG. In no cases do the specified conRl-B mutant, lacking Hyp 10 , and the conG mutant, with an insertion of Hyp 10 , function effectively in any of these neurons (Fig. 12, D-F) . However, the conG[O 10 ] mutant peptide shows a preference for inhibiting the GluN2A subunit (30%) when present in a GluN2B Ϫ/Ϫ background (Fig. 12F) . The antagonistic role of Hyp 10 was further pinpointed by the conRl-B[Hyp 10 /P] peptide. This mutant conantokin had similar inhibitory property as conRl-B in WT neurons (Fig. 12D) but became subunit-nonspecific as observed by decreased inhibitory activity (43%) in GluN2A Ϫ/Ϫ neurons (Fig. 12E ) and GluN2B Ϫ/Ϫ (23%) neurons (Fig. 12F ).
Discussion
Conantokins, a subset of conotoxins, from cone snails have been studied extensively for their unique structural and functional properties. Many of these peptides are extensively posttranslationally modified, with these peptides containing any of the side chains of Gla, Hyp, and Br-Trp, O-glycosylation on Ser and/or Thr, C-terminal amidation, disulfide bonds, and even truncation mutations (2, 21, 30, 54, 57) . Functionally, these large numbers of peptides from venoms of various species of predatory cone snails may have therapeutic benefit in humans because they allosterically block ion channels of the NMDAR, thus avoiding the pyschomimetic effects of direct channel blockers. NMDARs are highly structural and functional plastic receptors with numerous classes of subunits constituting the heterotetramer.
In the conantokin family of peptides, the presence of Gla side chains at the i,i ϩ 3, i ϩ 7, and i ϩ 11 positions is conducive to their binding to divalent ions, and the ability of cations to span Gla 3-4 residues apart is central to the induction of cation-dependent ␣-helical states (58, 59) . Sequential Ala mutational studies have provided the knowledge that substituting Gla with Ala disrupts the binding of divalent ions and attenuates the functional NMDAR antagonist properties of the peptides. This shows that the three-dimensional metal-bound conformation is essential for the target activity against NMDAR, and induction or stabilization of the ␣-helix is dependent on divalent cation binding for most of the known conantokins (60) . A notable exception to this point is the case of conT, which exists as an end-to-end helix in the presence or absence of divalent cations (55) . There are important features of apo-conT that make this possible. Whereas conantokins have highly conserved sequences of 1 GE␥␥ 4 as their N termini, sequence divergences are present subsequent to this point. In the case of conG, the following Gla 3 ϩ 4, Gla 4 ϩ 3, Gla 7 ϩ 3, and Gla 10 ϩ 4 residues are also Gla residues. This negatively charged network would lead to helix-destabilizing charge repulsions in an ␣-helix in the apopeptide, viz. the negative charges on closely positioned Gla residues would be neutralized by divalent cations, thus stabilizing the adoption of a metal ion-induced ␣-helix. However, conT possesses a Lys 7 residue, thereby bridging Gla 4 and Gla 10 by ion pairing and allowing a helix to form, which is even more stabilized by many favorable helical side-chain interactions, e.g. hydrophobic pairing of Tyr 5 and Met 8 , ion pairing between Gla 14 and Lys 18 , and between Glu 16 and Lys 19 (55) . This inherent ␣-helix is also further stabilized by divalent cation binding (42) .
ConRl-B, like conG, contains the helix-destabilizing network of Gla 3 -Gla 4 -Gla 7 -Gla 11 , as well as a putative helix breaker, Hyp 10 . Other side chains in conRl-B are not as extensive a set of helix stabilizers as are found in conT. Thus, it is not surprising that conRl-B lacks helical character in the apo-form. However, in the presence of divalent cations, negative charge repulsions are eliminated and the ␣-helix forms (30, 50, 61) . The further effect of Hyp 10 that is present in a central primary location of conRl-B on overall helix propensity of conRl-B is of interest, especially with regard to whether it destabilizes the global helix or is more simply a small region within the overall helix. From the structural analyses provided herein, it is seen that Hyp 10 in conRl-B or in the variant, conG[O 10 ], allows each terminus of the peptides to form helices with high negative character, optimal for interaction with divalent cations. This report represents the first high resolution structural analysis of a conantokin with Hyp.
It remains to be considered as to whether hydroxylation of Pro bestows any specific properties to this class of peptides, other than its dramatic influence on structure. It has been found that in isolated systems of Hyp and oocytes containing GluN1/GluN2, substitution of Pro for Hyp in conRl-B does not affect the specificity of the peptides for the GluN2B subunit. In other systems, Hyp is found as a major component in collagen and confers enhanced stability of the triple helix as compared with Pro, either by participating in the formation of an H-bonded stabilizing water network (62) and/or through stereoelectronic effects of the electronegative oxygen (63) . Applying this example to conantokins, it is possible that the incorporation of a relatively flexible region of the ␣-helix allows the peptide to stereospecifically adapt to its binding sites on the NMDAR by each end of the peptide's additional degrees of freedom. Many other specific functions of Hyp are possible, e.g. biological activity, assisting in receptor/ligand binding interactions via water bridging, enhancing protein stability and prevention of protein aggregation (64) , Hyp recognition in cell signaling (65) , and in accelerating oxidative folding of proteins (66) .
Determination of Divalent Metal Cation-binding Sites in conRl-B and Variant Peptides-In the presence of Mg 2ϩ , CD scans for conRl-B mutants showed that the removal of Hyp 10 modestly increased the distribution of its ␣-helical backbone, and the addition of Hyp at the same position as conRl-B in conG did not substantially interfere with the overall ␣-helical backbone at a saturating concentration of Mg 2ϩ . 1 Previous deletion mutation studies on conantokins revealed that Gla 10 and Gla 14 in the C-terminal region contribute toward the stability of the conantokin⅐receptor complex. In general, where the Gly 1 -Glu 2 -Gla 3 -Gla 4 -Xaa 5 -Xaa 6 in the N terminus is a determinant of the functional properties and selectivity of the conantokins, the C terminus is likely responsible for the anchoring of the peptide close to the site of activity (58, 59) . It was also concluded, by titrations of cations into selectively 13 C-enriched C␥ and C␦ of conG, that Gla 10 /Gla 14 was loaded with cations prior to the complex formed at Gla 3 /Gla 7 (67) . Therefore, the relative stability of the C terminus toward 2 H 2 O solvent exchange holds true for conRl-B and derived mutant peptides, responsible for directing these agents at the membrane surface to facilitate NMDAR targeting. The improvement of functional properties of stapled analogues of conG by structure stabilizing i,i ϩ 4 or i,i ϩ 7 di-carba bridges provides additional evidence of the correlation between three-dimensional structure, stability of conantokins, and their functional properties (68) .
Elucidation Table 1 ). The pres-ence of medium range NOE connectivities between Ala 9 and Phe 12 gives the Mg 2ϩ ⅐conRl-B complex a characteristic bend at the location of Hyp 10 , which is the initiator of ␣-helix at the C-terminal half of the peptide. This was more distinctly observed in the structure generated at 5°C, which was less dynamic and generated an increased number of NOE peaks. A more compact structure at a lower temperature resulted in a considerable shift in backbone H N and H ␣ signals from those observed at 25°C. The temperature-related difference is a probable reason for a more ambiguous prediction of the and angles of the backbone at 5°C for conRl-B. Interestingly, no significant changes in NOESY spectra were observed for Mg 2ϩ / conG[O 10 ] at 5°C, when compared with the spectra measured at 25°C. At both temperatures, no discernible NOE peaks were observed between Gln 9 and Leu 12 . Thus, the non-natural bend introduced by Hyp 10 allows conG[O 10 ] to adopt a different three-dimensional conformation than the natural bend in Hyp 10 -containing conRl-B. The 20 energy-minimized NMR solution structures generated by Xplor-NIH for Mg 2ϩ ⅐conRl-B were all restricted to certain allowed regions and, on superimposition, appear to be confined in movement. In comparison, conG[O 10 ], in the presence of Mg 2ϩ , appears more flexible at both lower (5°C) and higher (25°C) temperatures. These results provide a reliable prediction that conG[O 10 ] acts as two separate Mg 2ϩ -binding peptides attached by a flexible loop from Asn 8 to Leu 12 .
Relationship of Primary Sequence and Three-dimensional Structure to Bioactivity and GluN2 Subunit Specificity-Although Xenopus oocytes and HEK cell-containing cDNAs of specific NMDAR subunits have been extensively used by several laboratories in the field, fewer laboratories employ geneti- cally altered neurons to examine functional properties of conantokins. The NMDAR is a heterotetramer composed of two obligatory GluN1 subunits and two GluN2 subunits. It is established that heterogeneity of the GluN2A-D subunits imparts distinct biochemical, pharmacological, and electrophysiological properties to the functional ion channel (69) . The GluN2 subunits are populated in different regions of the central nervous system commensurate with their role in synaptic activity and plasticity (70 -72) . However, GluN2A and GluN2B are the principal subunits in hippocampal and cortical neurons. This heterogeneity confers distinct subunit-specific modulation of the NMDAR ion channel allowing discernment of their functional role utilizing pharmacological reagents. Small molecule compounds, e.g. ifenprodil and its derivatives, are GluN2Bspecific inhibitors (73) , whereas TCN-201 is a GluN2A-specific antagonist (74) . Recently, a new class of compounds, viz. DQP-1105, QNZ-46, and CIQ, which are GluN2C/GluN2D-specific modulators (75) (76) (77) , have been identified to aid in evaluating the role of NR2C and NR2D in pathophysiological functions of the NMDAR. Because in this investigation our purpose was to define the GluN2B-specific role of Hyp 10 in its native (conRl-B) and non-native backbone (conG), we have only utilized WT, GluN2A Ϫ/Ϫ , and GluN2B Ϫ/Ϫ neurons to determine the antagonistic properties of conRl-B and the necessity of the GluN2B subunit for the robust inhibition of the NMDA/Gly-mediated current.
The primary sequence of conRl-B is homologous to conG, with regard to the presence of Gla 3 , Gla 4 , Leu 5 , and Gla 7 , and an amidated C terminus. Previous specific residue mutagenesis studies performed on conG revealed that Leu 5 , in combination with Asn or a charged residue at position 8, is responsible for the majority of GluN2B selectivity (60) . Therefore, the GluN2B selectivity of conRl-B, as determined by its primary sequence, could be based on the presence of Leu 5 and Lys 8 . The importance of the ⑀-amino group of Lys 8 was indicated by the gain of GluN2A selectivity by conRl-B[K 8 N] (54) . Although conG [O 10 ] shares N-terminal residues with conG, it gains selectivity toward GluN2A, as shown by 50% inhibition of internal Ca 2ϩ in GluN2B Ϫ/Ϫ neurons, similar to conT (38%, data not shown), and 37% inhibition of inward current in GluN2B Ϫ/Ϫ neurons. To determine the inhibitory contribution of the GluN2C and/or GluN2D by the conantokins utilized in this study, electrophysiological and real time Ca 2ϩ imaging was performed utilizing GluN2C Ϫ/Ϫ and GluN2D Ϫ/Ϫ neurons. The inhibitory profile of these gene-deficient neurons was similar to WT neurons indicating that the GluN2C or GluN2D subunits are not targeted by the conantokins (data not shown).
In addition to the GluN1/GluN2A and GluN1/GluN2B diheteromers, the adult hippocampus, cortex, and other regions of the brain contain NMDARs that exist as triheteromeric complexes in different combinations of GluN2 subunits, of which the GluN1/GluN2A/GluN2B triheteromers are in highest abundance (Ͼ50%) (78, 79) . The triheteromeric channels not only exhibit distinctive deactivation kinetics but also display disparate pharmacological properties compared with GluN1/GluN2B diheteromeric receptors. Cells containing the GluN1/GluN2A/GluN2B exhibited deactivation kinetics and pharmacological properties that were representative of the GluN1/GluN2A diheteromer. The activities of other classical GluN2B antagonists, i.e. ifenprodil and CP-101,606, are manifestly diminished in cells containing the GluN1⅐GluN2A⅐ GluN2B complex compared with the GluN1⅐GluN2B diheteromers (80 -82) . Although the primary focus of this investigation is to study structure-function relationships of conantokins on the GluN2B subunit of NMDARs, the presence of GluN1/ GluN2A/GluN2B ion channels in WT cortical neurons likely explains the reason why maximal inhibition by conRl-B (80%) and conG (85%) is not observed in these cells, compared with inhibition by conRl-B (88%) and conG (Ͼ99%) in the GluN2A Ϫ/Ϫ neurons, where the triheteromeric GluN1/GluN2A/ GluN2B channels are not present.
From consideration of the deletion mutations of conantokins, it was concluded that Gla 10 and Gla 14 of the C terminus contribute toward the stability of the conantokin⅐receptor complex. In general, the C terminus is responsible for anchoring the peptide close to the site of action and/or in directing these agents at the membrane surface to facilitate NMDAR targeting (59) . The NMR-derived solution structure of Mg 2ϩ ⅐conRl-B at 5°C reveals the definitive existence of an ␣-helical C terminus beginning at Hyp 10 . Although the majority of the backbone amide proton signals disappeared in 2 H 2 O within 1 h, Gla 11 and Gla 15 conferred higher stability to the C terminus at 5°C. Because of the presence of medium range NOEs between Ala 9 and Phe 12 , the three-dimensional structure of conRl-B is found in a slightly bent conformation with the two ␣-helices, connected by the kink. The presence of a Hyp 10 creates a break in the ␣-helix backbone of conRl-B, which occupies 3 amino acid residues, but surprisingly it differs in flexibility from that same disruption introduced in conG[O 10 ], although Hyp is present at an identical position. Despite the identical distribution of Gla and residues from Gly 1 to Gla 11 , except for Ala 6 , and a similar three-dimensional structure to conG, conRl-B[⌬K 8 AON 8 Q] showed virtually no inhibition of NMDA/Gly-stimulated current influx in WT and GluN2A Ϫ/Ϫ neurons, as compared with conRl-B. This finding was in agreement with the results published previously, which reiterated the importance of the second inter-Gla fragment (54) . Because superimpositions of three-dimensional structures of conG and conRl-B[⌬K 8 AON 8 Q] do not show differences, and assuming that the critical nature of the N terminus determines the selectivity of conantokins toward NMDAR, conRl-B[⌬K 8 AON 8 Q] may lose its selectivity toward GluN2B due to the presence of Ala 6 , instead of Gln 6 , of conG. In contrast, the conRl-B[Hyp 10 /P] mutant peptide clearly demonstrated that switching the Hyp 10 to Pro 10 did not affect its antagonistic activity compared with conRl-B in WT neurons. However, conRl-B[Hyp 10 /P], although not as weak an antagonist as conRl-B[⌬K 8 AON 8 Q] or conG[O 10 ], appears to have lost its GluN2B specificity and gained GluN2A specificity, as observed by its inhibitory profile in GluN2A Ϫ/Ϫ and GluN2B Ϫ/Ϫ neurons. This indicates that Hyp 10 or Pro 10 confers antagonistic activity in WT neurons that contains the entirety of GluN2 subunits. However, when Hyp 10 was removed from its own backbone, in conRl-B[⌬K 8 AON 8 Q], both its antagonistic activity and GluN2B subunit specificity were highly diminished. When Hyp was inserted in conG[O 10 ], poor inhibition was observed in WT or GluN2A Ϫ/Ϫ neurons, but weak (37%) inhibition was observed in GluN2B Ϫ/Ϫ neurons, indicating that conG[O 10 ] is antagonistic when GluN2A is the major subunit in the absence of GluN2B.
In conclusion, we have solved the structures of related members of a class of conantokins that contain Hyp in their primary structures. Hyp locally disrupts a small region of the divalent cation-induced ␣-helix and does not destabilize the entire helix. Divalent cation binding is still present in the Hyp-containing peptides, although binding energies are not as strong as in peptides lacking Hyp. However, the strength of this binding is sufficient to allow the induction of the ␣-helical conformations. This Hyp residue, directly or indirectly, is a strong modifier of NMDAR subunit selectivity.
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